• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类对炭疽杆菌保护性抗原抗体反应的结构域特异性

Domain specificity of the human antibody response to Bacillus anthracis protective antigen.

作者信息

Reason Donald C, Ullal Anuska, Liberato Justine, Sun Jinying, Keitel Wendy, Zhou Jianhui

机构信息

Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA 94609, USA.

出版信息

Vaccine. 2008 Jul 29;26(32):4041-7. doi: 10.1016/j.vaccine.2008.05.023. Epub 2008 Jun 2.

DOI:10.1016/j.vaccine.2008.05.023
PMID:18565627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2536639/
Abstract

Protective antigen (PA) is the cell surface recognition moiety of the Bacillus anthracis A-B toxin system, and the active immunogenic component in the currently licensed human anthrax vaccine (BioThrax, or AVA). The serum antibody response to the PA protein is polyclonal and complex both in terms of the antibody combining sites utilized to bind PA and the PA-associated epitopes recognized. We have cloned, sequenced, and expressed a large panel of PA-specific human monoclonal antibodies from seven AVA-immunized donors. Dot blots, Western blots, and radiolabeled antigen capture assays employing both proteolytic fragments of PA and engineered PA sub-domain fusion proteins were used to determine the region (domain) of the PA monomer to which each of the cloned human antibodies bound. The domain specificity of the isolated monoclonals was highly biased towards the amino-terminal 20kDa fragment of PA (PA(20)), with the majority (62%) of independently arising antibody clones reacting with determinants located on this PA fragment. A similar bias in domain specificity was also demonstrated in the serum response of AVA-vaccinated donors. Since PA(20) is cleaved from the remainder of the monomer rapidly following cell surface binding and has no known role in the intoxication process, the immunodominance of PA(20)-associated epitopes may directly affect the efficacy of PA-based anthrax vaccines.

摘要

保护性抗原(PA)是炭疽芽孢杆菌A-B毒素系统的细胞表面识别部分,也是目前已获许可的人用炭疽疫苗(BioThrax,或AVA)中的活性免疫原成分。针对PA蛋白的血清抗体反应在用于结合PA的抗体结合位点以及所识别的PA相关表位方面都是多克隆且复杂的。我们从7名接种AVA的供体中克隆、测序并表达了大量PA特异性人单克隆抗体。采用PA的蛋白水解片段和工程化PA亚结构域融合蛋白进行的点杂交、蛋白质印迹和放射性标记抗原捕获分析,用于确定每个克隆的人抗体所结合的PA单体区域(结构域)。分离出的单克隆抗体的结构域特异性高度偏向于PA的氨基末端20kDa片段(PA(20)),大多数(62%)独立产生的抗体克隆与位于该PA片段上的决定簇发生反应。在接种AVA的供体的血清反应中也显示出类似的结构域特异性偏向。由于PA(20)在细胞表面结合后会迅速从单体的其余部分裂解下来,并且在中毒过程中没有已知作用,PA(20)相关表位的免疫显性可能直接影响基于PA的炭疽疫苗的效力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd4/2536639/b0c6395b637a/nihms64416f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd4/2536639/bde9bae9b839/nihms64416f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd4/2536639/9cf568369593/nihms64416f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd4/2536639/b0c6395b637a/nihms64416f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd4/2536639/bde9bae9b839/nihms64416f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd4/2536639/9cf568369593/nihms64416f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd4/2536639/b0c6395b637a/nihms64416f3.jpg

相似文献

1
Domain specificity of the human antibody response to Bacillus anthracis protective antigen.人类对炭疽杆菌保护性抗原抗体反应的结构域特异性
Vaccine. 2008 Jul 29;26(32):4041-7. doi: 10.1016/j.vaccine.2008.05.023. Epub 2008 Jun 2.
2
Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to anthrax vaccine adsorbed.人对吸附型炭疽疫苗抗体反应中毒素中和互补决定区的频率和结构域特异性
Infect Immun. 2009 May;77(5):2030-5. doi: 10.1128/IAI.01254-08. Epub 2009 Feb 17.
3
The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.抗炭疽芽孢杆菌抗体和炭疽毒素成分在抑制炭疽芽孢感染早期阶段中的作用。
Microbiology (Reading). 2001 Jun;147(Pt 6):1677-1685. doi: 10.1099/00221287-147-6-1677.
4
Paratope diversity in the human antibody response to Bacillus anthracis protective antigen.人类对炭疽芽孢杆菌保护性抗原抗体反应中的互补决定区多样性。
Mol Immunol. 2008 Jan;45(2):338-47. doi: 10.1016/j.molimm.2007.06.159. Epub 2007 Aug 17.
5
Vaccination of rhesus macaques with the anthrax vaccine adsorbed vaccine produces a serum antibody response that effectively neutralizes receptor-bound protective antigen in vitro.用吸附炭疽疫苗对恒河猴进行接种可产生血清抗体反应,该反应在体外能有效中和与受体结合的保护性抗原。
Clin Vaccine Immunol. 2010 Nov;17(11):1753-62. doi: 10.1128/CVI.00174-10. Epub 2010 Aug 25.
6
Neutralizing activity of vaccine-induced antibodies to two Bacillus anthracis toxin components, lethal factor and edema factor.疫苗诱导的针对两种炭疽杆菌毒素成分(致死因子和水肿因子)的抗体的中和活性。
Clin Vaccine Immunol. 2008 Jan;15(1):71-5. doi: 10.1128/CVI.00321-07. Epub 2007 Nov 21.
7
Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients.炭疽疫苗沉淀剂可诱导人类接种者产生中和水肿毒素、针对水肿因子的特异性抗体。
Clin Vaccine Immunol. 2017 Nov 6;24(11). doi: 10.1128/CVI.00165-17. Print 2017 Nov.
8
Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.炭疽芽孢杆菌保护性抗原结构域的免疫原性及所引发抗体反应的效力取决于宿主的遗传背景。
Clin Vaccine Immunol. 2008 Jul;15(7):1115-23. doi: 10.1128/CVI.00015-08. Epub 2008 May 14.
9
BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model.BA3338,一种具有表面层同源结构域的蛋白,增强了保护性抗原针对炭疽芽孢杆菌的免疫反应和保护效力,在小鼠模型中。
J Appl Microbiol. 2020 Aug;129(2):443-452. doi: 10.1111/jam.14624. Epub 2020 Mar 18.
10
Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine.接种重组保护性抗原疫苗后靶向炭疽保护性抗原的人单克隆抗体的产生与特性分析
Clin Vaccine Immunol. 2015 May;22(5):553-60. doi: 10.1128/CVI.00792-14. Epub 2015 Mar 18.

引用本文的文献

1
Anthrax Vaccines in the 21st Century.21世纪的炭疽疫苗
Vaccines (Basel). 2024 Feb 3;12(2):159. doi: 10.3390/vaccines12020159.
2
Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires.人类抗原特异性记忆 B 细胞 repertoire 分析的见解。
Front Immunol. 2019 Jan 15;9:3064. doi: 10.3389/fimmu.2018.03064. eCollection 2018.
3
Constructing and transient expression of a gene cassette containing edible vaccine elements and shigellosis, anthrax and cholera recombinant antigens in tomato.构建包含食用疫苗元件以及志贺氏菌病、炭疽和霍乱重组抗原的基因盒并在番茄中进行瞬时表达。

本文引用的文献

1
Anthrax protective antigen cleavage and clearance from the blood of mice and rats.炭疽保护性抗原在小鼠和大鼠血液中的裂解与清除
Infect Immun. 2007 Nov;75(11):5175-84. doi: 10.1128/IAI.00719-07. Epub 2007 Aug 27.
2
Paratope diversity in the human antibody response to Bacillus anthracis protective antigen.人类对炭疽芽孢杆菌保护性抗原抗体反应中的互补决定区多样性。
Mol Immunol. 2008 Jan;45(2):338-47. doi: 10.1016/j.molimm.2007.06.159. Epub 2007 Aug 17.
3
Recombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine.
Mol Biol Rep. 2018 Dec;45(6):2237-2246. doi: 10.1007/s11033-018-4385-3. Epub 2018 Sep 22.
4
The promise and challenge of epitope-focused vaccines.表位聚焦疫苗的前景与挑战
Hum Vaccin Immunother. 2016 Aug 2;12(8):2113-2116. doi: 10.1080/21645515.2016.1160977. Epub 2016 Apr 8.
5
Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.α毒素β孔道结构域中线性保护性中和表位的鉴定与验证
PLoS One. 2015 Jan 30;10(1):e0116882. doi: 10.1371/journal.pone.0116882. eCollection 2015.
6
Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.使用佐剂的靶向表位肽免疫原可保护兔子免受实验性吸入性炭疽感染。
Vaccine. 2015 Jan 9;33(3):430-6. doi: 10.1016/j.vaccine.2014.11.042. Epub 2014 Nov 30.
7
Identification of peptide sequences as a measure of Anthrax vaccine stability during storage.鉴定肽序列作为炭疽疫苗储存期间稳定性的一种衡量指标。
Hum Vaccin Immunother. 2014;10(6):1669-81. doi: 10.4161/hv.28443. Epub 2014 Mar 17.
8
MHC class II and non-MHC class II genes differentially influence humoral immunity to Bacillus anthracis lethal factor and protective antigen.MHC 类 II 基因和非 MHC 类 II 基因对炭疽致死因子和保护性抗原的体液免疫有不同影响。
Toxins (Basel). 2012 Dec;4(12):1451-67. doi: 10.3390/toxins4121451.
9
Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax.展示来自保护性抗原的环中和决定簇的重组疫苗可完全保护兔子免受实验性吸入性炭疽的侵害。
Clin Vaccine Immunol. 2013 Mar;20(3):341-9. doi: 10.1128/CVI.00612-12. Epub 2013 Jan 2.
10
Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen.一种针对炭疽芽孢杆菌保护性抗原 PA(20) 区域的人源单克隆抗体对致死毒素的中和作用机制。
Toxins (Basel). 2011 Aug;3(8):979-90. doi: 10.3390/toxins3080979. Epub 2011 Aug 9.
重组保护性抗原102(rPA102):第二代炭疽疫苗概况
Expert Rev Vaccines. 2006 Aug;5(4):417-30. doi: 10.1586/14760584.5.4.417.
4
Codon insertion and deletion functions as a somatic diversification mechanism in human antibody repertoires.密码子插入和缺失作为人类抗体库中的一种体细胞多样化机制。
Biol Direct. 2006 Aug 30;1:24. doi: 10.1186/1745-6150-1-24.
5
Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen.识别炭疽芽孢杆菌保护性抗原结构域2中一个表位的中和性单克隆抗体的制备与特性分析
FEMS Immunol Med Microbiol. 2006 Aug;47(3):436-43. doi: 10.1111/j.1574-695X.2006.00114.x.
6
Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.重组保护性抗原(rPA102)炭疽疫苗递增剂量的免疫原性和耐受性:一项随机、双盲、对照、多中心试验。
Vaccine. 2006 Aug 14;24(33-34):5950-9. doi: 10.1016/j.vaccine.2006.05.044. Epub 2006 Jun 5.
7
Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production.炭疽致死毒素对B细胞增殖和免疫球蛋白产生具有直接且强大的抑制作用。
J Immunol. 2006 May 15;176(10):6155-61. doi: 10.4049/jimmunol.176.10.6155.
8
An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program.疾病控制与预防中心炭疽疫苗及抗菌药物可及性项目参与者报告的不良事件概述。
Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):393-401. doi: 10.1002/pds.1085.
9
Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).炭疽疫苗的安全性:对向疫苗不良事件报告系统(VAERS)报告的不良事件进行的扩展审查与评估
Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):825-40. doi: 10.1002/pds.936.
10
Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum.人标准炭疽参考血清中总免疫球蛋白G及亚类的质量赋值
Clin Diagn Lab Immunol. 2004 Sep;11(5):919-23. doi: 10.1128/CDLI.11.5.919-923.2004.